Print

Print


I signed new consent slips last month to continue on the Cabergoline trial
(location of the clinic I attend changed).
The permission slip indicates drug company:  Pharmacia
Clinical trial stage 3 - long term usage.
 
The consent slip signed by patient to participate in study should contain
both drug company name and clinical trial stage.  You are entitled to said
information.
 
I have been on this trial for almost 3 years. Great D-2 agonist.
 
Rita Weeks